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We have used laboratory-based molecular modelling to identify structural features of antigen chtmaerns of poliovirus expressing epitopes from 
human immunodeficiency virus (HIV-l) that may affect virus viability. Chimaeras were constructed by replacement or antigenic site I of VP1 by 
sequences corresponding to epitopcs from HIV-l. Loop volume. estimated by approximating the loop to an ellipsoid was signiticantly (PiO.001) 
lower in viable (2062.1 Ali400.2) than in non-viable (3617 A3f650.7) constructs. Our results suggest that viable virus will only be formed when 
antigen chimearas modlficd at antigcnic site of VPI have a loop occupying a similar volume in space to that occupied by the antigenic site 1 loop. 
In addition, the modified loop must fit with the peptide bond angles and distances at the top of the&barrel ofVPl_ 
Vaccine: Molecular modelling; /?-Hairpin: Turn; AIDS \‘trus: Glycoprotein; Antibody reaction 
1. INTRODUCTION 
Poliovirus shares a number of structural features 
with other picorna viruses, notably the eight-stranded 
anti-parallel P-barrel core of the capsid proteins, VPI-3. 
While the amino acids making up the core show some 
conservation between viruses, the loops which join the 
core elements vary considerably in sequence and size, 
and some of these constitute antigenic determinants. 
Fig. 1 shows the capsid protein VP1 of the type 1 
(Mahoney) strain of poliovirus, with antigenic site 1 
(amino acids 91-102) indicated by the arrow. This loop 
forms a distinct surface projection at the pentameric 
apex of the icosahedral particle [l], separating /3 strands 
B and C, and is known to elicit neutralising antibodies 
in the three serotypes of poliovirus [2]. Our studies to 
construct improved poliovirus vaccines have involved 
the use of genetic engineering techniques to replace an- 
tigenic site 1 of Sabin 1 (the live attenuated vaccine 
strain) with the analogous sequence from a type 3 virus 
[3]. The success of these studies led to the design of a 
cassette vector, pCAS1, [3] to facilitate the extensive 
modification of antigenic site 1, and to the subsequent 
exploitation of the Sabin I strain of poliovirus as an 
epitope expression vector. This system has been used to 
construct in excess of 50 antigen chimaeras, expressing 
known or predicted antigenic determinants from a wide 
range of pathogens. However, we have been unable to 
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recover viable virus chimaeras from several cDNA con- 
structs, presumably due to a block in a vital stage of the 
virus replication cycle, e.g. polyprotein folding, 
maturation, capsid assembly, receptor binding or virus 
uncoating. Studies are currently underway to determine 
whether chimaeras designed to express related se- 
quences are blocked at the same point. 
We have now initiated a programme of molecuIar 
modelling to characterise the modified antigenic site I 
of a number of viable and non-viable constructs to 
establish structural guidelines around which future 
viable chimaeras may be designed. Modelling 
topoIogica1 elements is of interest in structural studies 
I411 and reasonably successful structure predictions 
have been made of immunoglobulin hypervariable 
regions [5,6]. In this paper we describe the modelling of 
chimaeras where antigenic site 1 has been replaced by 
residues corresponding to epitopes from human im- 
munodeficiency virus type 1 (HIV-l). As the number of 
residues in the loop under consideration is 18 or less, we 
have used the convenient Desk Top Molecular Modeller 
(DTMM) and Alchemy II software packages, developed 
for use on IBM PC-compatible computers. These use 
molecular n~echanics force-field calculations [7] based 
on the COSMIC system [S] for energy minimisation. 
2. MATERIALS AND METHODS 
2.1. hardware 
Database searches and protein co-ordinates from the Brookhnven 
Data Bank 191 were obtained from the SEQNET VAX computer at 
Daresbury, Cheshire, UK. Modelling was performed on an IBM PS/2 
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Fig. 1. The peptide chain, together with basic residue side chains, for VP1 of the Sabin type 1 (Mahoney) strain of polio virus. Atomic co-ordinates 
are from [l], downloaded from the Brookhaven Protein Data Bank. Antigenic loop 1 is indicated by an arrow. 
Model 80 with 80387 co-processor, and a Victor V286C with 80287 co- 
processor. 
2.2. Model(ing 
Desk Top Molecular Modeller (DTMM) version 1.2 (Oxford Elec- 
tronic Publishing, Oxford University Press, Oxford OX2 6DP, UK) 
and Alchemy 11 (Tripos Associates Inc., St. Louis, MO 63144, USA) 
were used for molecular model building and quantitative calculations. 
We have used a knowledge-based approach to modelling rather than 
an ab initio conformational search algorithm [6]. The accuracy of the 
modelling method for loops was checked by building the antigenic site 
1 loop of VPl, the @-hairpin loops from Immunoglobulin FAB New 
(light chain) (residues L64-L71 and 89-L98), and the P-hairpin loops 
from S. griseus prorease A (residues 31-42 and 199-210) based on 
their amino acid sequences and including potential hydrogen bonds 
where appropriate [lo), and checking their identity after minimisation 
against the X-ray structures, as described previously [II ,121. There 
were no significant differences (< 10%) in hydrogen bonding 
distances or 6.4 peptide angles between actual and predicted strut- 
tures, while distance root mean square deviations between X-ray and 
minimised structures were 5 0.25 A. 
Fig. 2 shows the sequences of the loops studied. The Brookhaven 
database was searched for sequence similarities of loops in order to 
provide starting conformations where appropriate. Starting confor- 
mations of loops from viable gp41 (C), gp120 (D) and CD4 (N) 
chimaeras were based on similar sequences in turns capped by -Cly- 
Gly-,Pro-Gly- and the -He-Ser-Cys-Ser-Ser- loop region of pep- 
sinogen respectively [lo]. Otherwise, starting conformations were 
based on the antigenic site 1 loop of VPl. All loops exhibited 
minimum energy conformations of between 250-400 kJ/mol; [here 
was no correlation between minimum energy and other parameters 
studied. 
Accessible surface areas and hydrophilicities were estimated over 
each loop, summing values (based on solvent parameter values) for in- 
dividual amino acids [ 13,141. 
Loop lengths were estimated by measuring distances from the 
amide nitrogen of Asp (VP1 93) to the top of the loop. 
Loop volumes were estimated by approximating the loop to an 
ellipsoid, measuring loop length and ellipsoid radii, and calculating 
volume according to: 
4/‘37rabc 
where Q = loop length/Z; b, c are the radii of the loop at 90” to each 
other and to the major axis of the loop. Ellipsoids have been used to 
assess protrusion indices in the protruding regions of proteins [Is]. 
Virus viability was assessed as described previously [2,3]. 
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A: VD I 
0: I 
c: I 
D: I 
E: I 
F: I 
G: I 
H: I 
I. I 
J. I 
K: I 
L: I 
M: I 
N: I 
0: I 
NPASTTNKD I KL 
NSASTKNKF I 
RPEGIEEEGGERDRDRS I 
KSIRIQRGPGRAFVTIG I 
IQRGPGRAF I 
KSIRIQRGPGRAF I 
IQRGPGRAFVTIG I 
NSIRIQRGPGRAFVTIGD I 
NSIRIQRGLGRAFVTIGD I 
NSIRIQRGPGGAFVTIGD I 
NSIRIQRGLGGAFVTIGD I 
NGG I 
NMWQEVGKAMYAPPISGI 
NAPPISGQISCSSNID I 
NLPCRIKOFINMWQEVG I 
Fig. 2. Peptide sequences of the native and chimaeric polio virus con- 
structs (A-O) studied. The residues VD (amino end) and KL (carboxy 
end), where the loop meets the beta barrel, were conserved 
throughout. (A) sequence of the loop in VP1 of the type 1 Mahoney 
strain of polio virus [I]; (B) sequence of the loop used in the cassette 
vector pCASl [3]; (C) sequence of the chimaera incorporating the 
epitope from transmembrane glycoprotein gp41 (residues 735-752) of 
HIV-1 (Sl/env/3) [15]; (D-K) sequences of the chimaeras incor- 
porating epitopes (GPGR) from the envelope glycoprotein of HIV-l; 
(L) sequence of the chimaera where the loop has been deleted; (M) se- 
quence of the chimaera incorporating the epitope from the CD4 bind- 
ing site of gpl20; (N) sequence of the chimaera incorporating C- 
terminal residues from the epitope from the CD4 binding site of 
gpl20; (0) sequence of the chimaera incorporating N-terminal 
residues from the epitope from the CD4 binding site of gpl20. 
3. RESULTS AND DISCUSSION 
We have recently reported the construction of a 
Sabin l-derived antigen chimaera expressing residues 
735-752 of the transmembrane glycoprotein (gp41) of 
HIV-I [16]. This sequence was chosen as it represents a 
relatively well-characterised group-specific neutralisa- 
tion epitope of HIV-l, and therefore a potential can- 
didate for inclusion in future subunit vaccines. The 
most extensively studied neutralisation epitope of 
HIV-I occupies residues 307-321 of gp120 (all number- 
ing from the BRU isolate [ 171, This region of divergent 
virus isolates is characterised by the presence of a highly 
conserved NH+Zly-Pro-Gly-Arg-COOH sequence, 
which is predicted to form a p turn structure that caps 
a loop held at the base by a conserved disulphide bond. 
We have used PC-based molecular modelling to com- 
pare energy-minimised loops from viable and non- 
viable antigen chimaeras to identify structural features 
that may affect viability. The sequences modelled (Fig. 
2) include loops from poliovirus type 1 Mahoney (A) 
and the cassette vector pCAS1 (B), together with viable 
(C-D) and non-viable (E-K) poliovirus:HIV-1 
chimaeras. Also shown are viable (M,N) and non-viable 
(0) constructs where antigenic site 1 was replaced by 
Table I 
Critical peptide distances, angles, hydrophilicity values, accessible surface areas, volumes and virus viability for a series of natural and chimaeric 
virus constructs based on antigenic site 1 of polio virus (VP1 amino acids 91-102). The sequences of the constructs are given in Fig. 2. Distances 
are given in Angstroms (A), angles in degrees, accessible surface areas in A’, volumes in A3 
Cons. Viable N-C c-c C-N N-N Phi Psi Hphil S.A. Length Volume 
A 
B 
C 
D 
E 
F 
G 
H 
I 
J 
K 
L 
M 
N 
0 
Yes 5.74 4.79 7.99 7.42 
Yes 5.75 4.83 7.13 7.41 
Yes 5.69 4.78 8.06 7.44 
No 6.01 5.87 8.37 7.89 
No 5.68 4.98 8.05 7.31 
No 16.50 15.10 16.94 17.45 
No 10.49 10.87 17.39 17.03 
No 7.51 6.90 9.27 7.66 
No 7.43 6.90 9.29 7.63 
No 7.52 6.90 9.27 7.68 
No 7.43 6.90 9.29 7.63 
Yes 5.74 4.99 7.99 7.25 
Yes 5.86 5.03 8.32 7.72 
Yes 7.40 6.01 8.30 8.50 
No 5.74 4.80 8.11 7.49 
137.02 - 84.36 5.4 1325 15.44 2438.6 
140.11 - 100.81 3.6 1415 15.33 2527.3 
136.51 - 96.38 31.5 2810 29.13 1499.2 
- 39.94 152.34 2.2 2685 24.04 4419.0 
124.24 -100.91 1.4 1425 15.45 3198.3 
- 40.90 151.97 5.9 2140 23.24 4003.1 
124.24 - 100.91 -2.3 1970 16.46 2854.5 
- 39.94 152.34 2.4 2795 24.04 2758.3 
-41.21 153.65 0.6 2820 23.77 3135.7 
-41.44 153.34 ~ 0.6 2645 24.04 3870.5 
-41.21 153.65 -2.4 2670 23.77 3591.3 
135.86 - 83.86 0.2 310 7.56 1649.6 
139.08 - 98.92 - 5.4 2700 28.50 2360.6 
147.00 - 115.00 -2.1 2250 28.74 1897.5 
134.74 - 118.65 -3.5 2975 27.60 4725.4 
N-C-distance between the amide nitrogen of Asp (VP1 93) and the carboxyl carbon of Lys (VP1 103) where the loop meets the &barrel. The mean 
distance for viable constructs was 6.03 A + 0.61 (non-viable 7.366 A t 2.75, P>O.5); C-C-distance between the side chain carboxyl carbon atom 
of Asp (VP1 93) and the carboxyl carbon of Lys (VP1 103). The mean distance for viable constructs was 5.07 A f 0.43 (non-viable 7.69 A i 
3.10, P>O.3); C-N-distance between the side chain carboxyl carbon atom of Asp (VP1 93) and the epsilon amino nitrogen of Lys (VP1 103). The 
mean distance for viable constructs was 7.62 A f 0.41 (non-viable 10.65 A k 3.5, P>O.3); N-N=distance between the amide nitrogen of Asp 
(VP1 93) and the epsilon amino nitrogen of Lys (VP1 103). The mean distance for viable constructs was 7.62 A f 0.41 (non-viable 9.75 A k 4.00, 
P> 0.5). Phi = the phi peptide angle between Asp (VP1 93) and the next residue in the loop. The mean phi angle for viable constructs was 139.26 
+ 3.7 degrees; Psi, the psi peptide angle between Asp (VP1 93) and the next residue in the loop. The mean psi angle for viable constructs was 
-96.56 i 10.5 degrees. Phi-psi angles were also measured at the other end of the loop where Lys (VP1 103) is the conserved residue; a similar pattern 
of results was obtained. HPhil= hydrophilicity values of each loop determined as described in the text. S.A. = accessible surface area for each loop 
determined as described in the text. Length=length of the peptide chain from the amide nitrogen of Asp (VP1 93) to the top of the loop. 
Volume = estimated volume for each loop, calculated as described in the text. 
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regions shown to be involved in binding the cellular 
receptor CD4 [ 181, and a loop derived from a viable 
construct in which antigenic site 1 was largely deleted 
and replaced with the sequence -N-G-G- (L). The X-ray 
structure of antigenic site 1 of VP1 [l] (Fig. 3A) was us- 
ed as the basis for all comparisons. The distance root 
mean square deviation for the a-carbon atoms was 0.15 
A. The substitution of Asp-102 with Phe, due to the in- 
troduction of a restriction site during the construction 
of pCAS1, produced no significant quantitative dif- 
ferences in the peptide, and did not affect virus viabili- 
ty. Similarly, deletion of the loop and replacement with 
the sequence -Asn-Gly-Gly- (L in Fig. 2) did not affect 
viability or the positions of the P-barrel residues. 
Table I shows critical peptide distances, phi,psi 
angles, hydrophilicity indices, accessible surface areas, 
loop lengths and estimated volumes for the sequences in 
Fig. 2, together with an assessment of virus viability. 
Statistical estimates for viable bond distances and 
angles are given in the table legend. Viable constructs all 
gave distances and angles to within about 10% of one 
another. While some non-viable constructs were outside 
this limit by over loo%, some non-viable constructs ex- 
hibited distances and angles not significantly different 
(P<O.OS) from those in viable constructs. Thus while 
there are limits in key distances and angles where the 
loop joins the beta-barrel of VPl, at least one other 
parameter must also be important. Accessible surface 
area was lower in viable constructs (1801.6 A2 k 
878.11) than in non-viable constructs (2458.0 A2 + 
447.2), but this was not significant (PcO.2). 
Hydrophilicity was higher in viable constructs (11.53 f 
12.14) than in non-viable ones (6.41 + 2.78), but again 
this was not significant (P>O.5). There was no signifi- 
Fig. 3. Native and predicted structures of antigenic site 1 of poliovirus VP1 and chimaeras. (A) X-ray structure of antigenic site 1 on VP1 - atomic 
co-ordinates are from [1], downloaded from the Brookhaven Protein Data Bank. (B) Predicted structure of the viable construct incorporating the 
epitope from transmembrane glycoprotein gp41 of HIV-l (Sl/env/3) (C in Fig. 2). (C) Predicted structure of a non-viable construct incorporating 
an epitope (GPGR) from the envelope glycoprotein of HIV-l (H in Fig. 2). (D) Predicted structure of a viable construct incorporating the C- 
terminal section of the CD4 binding site of gpl20 (N in Fig. 2); (E) Predicted structure of a non-viable construct incorporating the N-terminal sec- 
tion of the CD4 binding site of gpl20 (0 in Fig. 2). 
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cant difference in mean length between viable and non- 
viable constructs (20.78 A of- 8.42; 21.80 i\ ? 6.0; 
P>O.6). 
Estimated loop volume, however, showed a very 
significant (P< 0.001) difference between viable (2062. I 
A’ -t 400.2) and non-viable (3617 A3 f 650.7) con- 
structs. Of particular interest is the chimaera based on 
the transmembrane glycoprotein of gp41 (C, Fig. 3B), 
which was found to form a viable virus and to elicit 
broadly reactive HIV-l neutralising antibodies [16]. 
Although the region analogous to antigenic site 1 of this 
virus was extended by 9 amino acids (Fig. 3B), the 
estimated volume of the loop was not significantly dif- 
ferent from the native structure, and there were no 
significant changes in the parameters where the loop 
met the P-barrel residues. Similarly, there were no 
significant differences in estimated loop volume or 
parameters where the loop met the P-barrel for the 
viable constructs based on all (M in Fig. 2) or the C- 
terminal region section (N in Fig. 2; Fig. 3d) of the CD4 
binding site of gp120. 
In contrast, the gpl20-derived sequences containing 
the -Gly-Pro-Gly-Arg- motif all showed significant 
changes in the peptide parameters, particularly in the 
distances across the peptide loop (Fig. 3C), as well as 
the estimated loop volumes, and all were non-viable. 
This was also true of the non-viable construct based on 
the N-terminal section of the CD4 binding site of gp120 
(Fig. 3E), where exposed aromatic side chains may 
cause significant perturbations around the loop, as well 
as a significant increase in estimated loop volume. 
These studies suggest that viable virus will only be 
formed when antigen chimaeras modified at antigenic 
site 1 of VP 1 have a loop occupying a similar volume in 
space to that occupied by the antigenic site 1 loop. In 
addition, the modified loop must fit with the peptide 
bond angles and distances at the top of the beta-barrel 
of VPl. The B-C loop modified during these studies 
projects at the pentameric apex of the icosahedral virus 
particle, and is situated between the D-E loop (which is 
located closer to the pentameric apex) and the ‘canyon’ 
or cleft in the capsid face, which has been suggested as 
the receptor-binding region of the virus [19]. It is possi- 
ble that the increased volume of the B-C loop in the 
nonviable chimaeras described here could interact 
adversely with the D-E loop, and so sterically hinder 
capsid formation and/or stability. Alternatively, the 
projecting loop may partially occlude the canyon, and 
SO prevent the virus interacting with its cellular 
receptor. 
Of the chimaeras containing the -G-P-G-R- sequence, 
E (-I-Q-R-G-P-G-R-A-F-) showed the most similarity to 
the native structure; only the predicted volume of the 
loop was significantly greater than that for the native 
structure. We would predict that replacing arginine 
residue 96 in construct E (Fig. 2) by an asparagine 
residue would lower the estimated volume to 2491.6 A3, 
198 
almost to within 1 S.D. of the estimated mean volume 
for viable constructs, and might result in the formation 
of viable chimaeric virus. However, when this construct 
was produced, we could not recover viable virus con- 
structs. This may be because replacement of one amino 
group on arginine by a carboxyl group on asparagine in- 
terferes with capsid formation and/or stability. 
These results show that we have the foundation of a 
technique, based on estimates of loop volumes and key 
peptide distances and angles, to assess and predict the 
viability of related chimaeric virus constructs. Using 
PC-based modelling tools facilitates modelling of small 
loop constructs to be performed at the bench, thus ex- 
pediting production of chimaeric viruses and potential 
vaccines. We have already initiated studies with 
poliovirus:SIV chimaeras and with chimaeras based on 
antigenic sites within VP3. 
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